glp 1 going grey GLP-1 Agonists and Food Consumption Still clinically proven. Still FDA-approved.

Her advice to colleagues who are treating people with obesity and low testosterone is not to prescribe "testosterone immediately, look at the broader picture." This article is reproduced with permission and was first published on June 15, 2026 .

The standard clinical protocol involves gradual dose escalation designed to minimize gastrointestinal side effects while building toward therapeutic levels

Re-estimating the linear regression analysis models after excluding potential outliers yielded consistent results

In early 2026, the FDA publicly announced its intent to take enforcement action against certain mass-marketed non-FDA-approved GLP-1 products